Professional Documents
Culture Documents
2137 Full
2137 Full
2137 Full
ORIGINAL RESEARCH
Received December 11, 2013, from the Departments of Radiology (G.S., N.J.H., J.F.P.) and
Vascular Surgery (J.M.E., J.M.A.-C.), Tufts Medical Center, Boston, Massachusetts USA. Revision
requested January 6, 2014. Revised manuscript
accepted for publication March 28, 2014.
Address correspondence to Gajan Sivananthan,
MD, Department of Radiology, Tufts Medical
Center, 800 Washington St, Box 299, Boston, MA
02111 USA.
E-mail: gsivananthan@tuftsmedicalcenter.org
Abbreviations
2014 by the American Institute of Ultrasound in Medicine | J Ultrasound Med 2014; 33:21372143 | 0278-4297 | www.aium.org
of the first examination. We also reviewed the primary indication for the study and the patient information sheet provided for each study.
Computed Tomographic Pulmonary Angiography
Computed tomographic pulmonary angiography was performed on either a Somatom Sensation (16-detector) or a
Somatom Definition (64-detector) device (Siemens AG,
Forchheim, Germany). Studies were performed after injection of 70 mL of iopamidol (Isovue 370; Bracco SpA,
Milan, Italy) at a rate of 5 mL/s. Acquisition was started
from a locator slice centered on the main pulmonary artery
when the average density within a region of interest reached
40 Hounsfield units above the baseline Hounsfield unit.
Diagnosis of an acute pulmonary embolus was made
in cases of a central intraluminal filling defect, a peripheral
intraluminal filling defect forming acute angles with a vessel
wall, or total cutoff of vascular enhancement. A diagnosis
of a chronic pulmonary embolus was made in cases of
Table 1. Wells and Simplified Wells Scores
Simplified
Wells Score Wells Score
Parameter
Clinical signs and symptoms of DVT
PE most likely diagnosis
Surgery or bedridden for >4 d
within the past 4 wk
Previous PE or DVT
Heart rate >100 beats/min
Hemoptysis
Active cancer
3
3
1
1
1.5
1.5
1.5
1
1
1
1
1
1
1
Parameter
Age 65 y
Previous PE or DVT
Surgery or fracture within 1 mo
Active cancer
Unilateral lower extremity pain
Hemoptysis
Heart rate 7594 beats/min
Heart rate >94 beats/min
Unilateral lower extremity edema
and tenderness
Revised
Geneva Score
Simplified
Revised
Geneva Score
1
3
2
2
3
2
3
5
1
1
1
1
1
1
1
2
Results
The mean age of the population SD was 58.7 17.4 years
with 39.2% men (56 of 143). At the time of the studies, most
patients were inpatients (73.5% [108 of 147]). There were
J Ultrasound Med 2014; 33:21372143
Angiography
First (n = 65)
Bed rest
Pain
Shortness of breath
Swelling
Miscellaneousa
Sonography
First (n = 82)
5
13
31
10
6
8
33
12
21
8
Indication
Bed rest
Pain
Shortness of breath
Swelling
Miscellaneousa
Negative
Sonographic
Findings
(n = 106)
Positive
Sonographic
Findings
(n = 41)
Total
8
30
32
25
11
5
16
11
6
3
13
46
43
31
14
2139
Discussion
We found that the rate of DVT in patients undergoing CT
pulmonary angiography was high, irrespective of positive or
negative angiographic findings for PE. Although the rate of
DVT in patients with PE was 51.4%, it was still substantial,
at 20.5%, in patients with negative angiographic findings.
In our practice, positive venous sonographic findings led
to anticoagulation or IVC filter placement in 18 of 23 cases
that had positive sonographic findings for DVT despite
negative angiographic findings.
Our detection rate for DVT in the proximal deep veins
in patients with negative angiographic findings was 5.4%
(95% confidence interval, 2.5%11.2%), which was higher
than the values of 2.4%, 3%, and 3.7% reported by other
investigators but within the 95% confidence intervals.1517
By performing a complete lower extremity sonographic
examination, our overall rate for DVT increased to 20.5%
Table 6. Patients With Positive CT Pulmonary Angiographic Findings
Finding
Any DVT
Proximal DVT
OR
Age, per y
Male
Interval between studies, h
Sonography first
Indicationa
Inpatient
Positive sonographic findings
1.02
1.85
1.01
0.59
0.40
1.76
3.90
Lower
Upper
95% OR 95% OR
0.99
0.84
0.96
0.24
0.18
0.71
1.66
1.04
4.08
1.06
1.42
0.87
4.40
9.60
P
.21
.13
.74
.26
.02
.22
.0017
2140
Lower Extremity
Symptoms
(n = 13)
11/13 (61.1)
8/11 (72.7)
No Lower Extremity
Symptoms
(n = 22)
P
7/22 (38.9)
4/7 (57.1)
.005
.63
Finding
Any DVT
Proximal DVT
Lower Extremity
Symptoms
(n = 66)
12/66 (18.2)
4/12 (33.3)
No Lower Extremity
Symptoms
(n = 46)
P
11/46 (24.9)
2/11 (18.2)
.48
.64
studies observed in tertiary care institutions.14 This phenomenon appears to be linked to increased clinical selection
of patients for both CT pulmonary angiographic and lower
extremity venous sonographic studies.14
Major limitations of our study include the retrospective design and the nature of our patient population, which
was representative of that seen in a tertiary care institution.
As such, the findings could be biased. We believe that any
bias, if present, is in favor of a patient subset with a high
clinical suspicion of thromboembolic disease. We cannot
support this hypothesis without prospective evaluations of
the clinical probability of PE and DVT based on decision
rules. However, our findings complement recent observations showing that a surveillance bias increases rather than
decreases the diagnostic yield of imaging tests for individuals with suspected DVT or PE.14 Were it not for this phenomenon, we would have expected much lower rates of
DVT and PE: likely on the order of 10% or less. However,
our prevalence rates for PE (23.8%) and lower extremity
DVT (27.9%) were higher than those generally reported15,16
and are consistent with the selection of a patient group
with a high a priori likelihood for thromboembolic disease.
This likely clinical selection bias can only be verified by
prospectively evaluating risk scores before venous
sonographic and CT pulmonary angiographic studies.
Our reliance on clinical data generated by the ordering
physicians could have possibly masked important clinical
traits that are associated with a higher rate of PE and DVT.
In conclusion, we found a high rate of DVT in a population undergoing CT pulmonary angiography for suspected PE. Although, as expected, this rate was high in
cases with PE, we also observed a high rate of DVT in individuals without PE, albeit mostly isolated calf vein DVT.
Our data suggest a possible patient selection bias toward a
patient subset with a high risk of thromboembolic disease
and demonstrate the possible utility of venous sonography
in this population. This hypothesis can only be further be
investigated by a prospective study.
References
1.
2.
3.
2142
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism:
a systematic review. JAMA 2005; 293:20122017.
Musset D, Parent F, Meyer G, et al. Diagnostic strategy for patients with
suspected pulmonary embolism: a prospective multicentre outcome
study. Lancet 2002; 360:19141920.
Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of
helical computed tomography in the diagnosis of pulmonary embolism:
a systematic review. Ann Intern Med 2000; 132:227232.
Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G.
Systematic review and meta-analysis of strategies for the diagnosis of
suspected pulmonary embolism. BMJ 2005; 331:259.
Huisman MV, Klok FA. Diagnostic management of clinically suspected
acute pulmonary embolism. J Thromb Haemost 2009; 7(suppl 1):312
317.
Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed
tomography for acute pulmonary embolism. N Engl J Med 2006;
354:23172327.
Jimnez D, Aujesky D, Daz G, et al. Prognostic significance of deep vein
thrombosis in patients presenting with acute symptomatic pulmonary
embolism. Am J Respir Crit Care Med 2010; 181:983991.
Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical
model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost
2000; 83:416420.
Douma RA, Gibson NS, Gerdes VEA, et al. Validity and clinical utility of
the simplified Wells rule for assessing clinical probability for the exclusion
of pulmonary embolism. Thromb Haemost 2009; 101:197200.
Klok FA, Mos ICM, Nijkeuter M, et al. Simplification of the revised
Geneva score for assessing clinical probability of pulmonary embolism.
Arch Intern Med 2008; 168:21312136.
Bilimoria KY, Chung J, Ju MH, et al. Evaluation of surveillance bias and the
validity of the venous thromboembolism quality measure. JAMA 2013;
310:14821489.
Cham MD, Yankelevitz DF, Henschke CI. Thromboembolic disease
detection at indirect CT venography versus CT pulmonary angiography.
Radiology 2005; 234:591594.
Hunsaker AR, Zou KH, Poh AC, et al. Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography.
AJR Am J Roentgenol 2008; 190:322326.
Krishan S, Panditaratne N, Verma R, Robertson R. Incremental value of
CT venography combined with pulmonary CT angiography for the
detection of thromboembolic disease: systematic review and metaanalysis. AJR Am J Roentgenol 2011; 196:10651072.
Elias A, Colombier D, Victor G, et al. Diagnostic performance of complete lower limb venous ultrasound in patients with clinically suspected
acute pulmonary embolism [published erratum appears in Thromb
Haemost 2004; 91:635]. Thromb Haemost 2004; 91:187195.
Righini M, Paris S, Le Gal G, Laroche JP, Perrier A, Bounameaux H.
Clinical relevance of distal deep vein thrombosis: review of literature data.
Thromb Haemost 2006; 95:5664.
J Ultrasound Med 2014; 33:21372143
20. Palareti G, Cosmi B, Lessiani G, et al. Evolution of untreated calf deepvein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 2010; 104:10631070.
21. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ;
American College of Chest Physicians. Antithrombotic therapy for
venous thromboembolic disease: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition) [published
erratum appears in Chest 2008; 134:892]. Chest 2008; 133(suppl):454S
545S.
22. Kearon C, Akl EA, Comerota AJ, et al; American College of Chest
Physicians. Antithrombotic therapy for VTE disease: Antithrombotic
Therapy and Prevention of Thrombosis, 9th ed: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest
2012; 141(suppl):e419Se494S.
23. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schnemann HJ;
American College of Chest Physicians Antithrombotic Therapy and
Prevention of Thrombosis Panel. Executive summary: Antithrombotic
Therapy and Prevention of Thrombosis, 9th ed: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines [published
erratum appears in Chest 2012; 141:1129; dosage error in article text].
Chest 2012; 141(suppl):7S47S.
24. Hirsh J, Guyatt G, Albers GW, Harrington R, Schnemann HJ; American
College of Chest Physicians. Executive summary: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [published erratum appears in Chest 2008; 134:892]. Chest 2008;
133(suppl):71S109S.
25. Girard P, Sanchez O, Leroyer C, et al. Deep venous thrombosis in patients
with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest 2005; 128:15931600.
26. Galanaud JP, Quenet S, Rivron-Guillot K, et al. Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11,086 patients. J Thromb Haemost 2009;
7:20282034.
27. Kovac M, Mitic G, Mikovic Z, et al. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A
mutation versus patients with no mutation. Clin Appl Thromb Hemost
2010; 16:6670.
28. Worsley DF, Alavi A. Comprehensive analysis of the results of the
PIOPED Study: Prospective Investigation of Pulmonary Embolism Diagnosis Study. J Nucl Med 1995; 36:23802387.
2143